Web Stats Provided By Google Analytics

Thursday, March 28, 2013

Biogen Idec's TECFIDERA™ (Dimethyl Fumarate) Approved in...

Today Biogen Idec announced that the U.S. Food and Drug Administration has approved TECFIDERA , a new first-line oral treatment for people with relapsing forms of multiple sclerosis .

http://www.andhranews.net/Intl/2013/Biogen-Idecs-TECFIDERA-Dimethyl-Fumarate-Approved-506.htm

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts